Clinical presentations and treatment for 74 occult thyroid carcinoma: Comparison with nonoccult thyroid carcinoma in Taiwan

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 5, 1996, Pages 504-508

  Lin, Jen Der ^a   Chao, Tzu Chieh ^b   Weng, Hsiao Fen ^b   Huang, Hong So ^b   Ho, Yat Sen ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

131I treatment; Occult thyroid carcinomas; Total thyroidectomy; Well differentiated thyroid cancer

Indexed keywords

IODINE 131; TECHNETIUM 99M;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER RADIOTHERAPY; CANCER SURVIVAL; ECHOGRAPHY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEEDLE BIOPSY; OCCULT CANCER; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 0029788849     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199610000-00015     Document Type: Article

References (24)

1. Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid: a study of 408 autopsy cases. Cancer 1990;65:1173-9.
2. Ottino A, Pianzola HM, Castelletto RH. Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina. Cancer 1989;64:547-51.
3. Franssila KO, Harach HR. Occult papillary carcinoma of the thyroid in children and young adults: a systemic autopsy study in Finland. Cancer 1986;58:715-9.
4. Allo MD, Christianson W, Koivunen D. Not all "occult" papillary carcinomas are "minimal." Surgery 1988;104:971-6.
5. Strate SM, Lee EL, Childer JH. Occult papillarycarcinoma of the thyroid with distant metastases. Cancer 1984;54:1093-100.
6. Kasai N, Sakamoto A, New subgrouping of small thyroid carcinoma. Cancer 1987;60:1767-70.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:475-81.
8. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:197-219.
9. Samaan NA, Maheshwari YK, Nader S, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983;56:1131-8.
10. Hrafnkelsson J, Jonasson JG, Sigurdsson G, Sigvaldason H, Tulinius H. Thyroid cancer in Iceland 1955-1984. Acta Endocrinol 1988;118:566-72.
11. Simpson WJ, McKinney SE. Canadian survey of thyroid cancer. Can Med Assoc 1985;132:925-31.
12. Farid NR, Shi Y, Zou M. Molecular basis of thyroid cancer. Endocrine Rev 1994;15:202-32.
13. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-53.
14. Simpson WJ, Mckinney SE, Carruthers JS, et al. Papillary and follicular thyroid cancer-prognostic factors in 1578 patients. Am J Med 1987;83:479-88.
15. Krausz Y, Uziely B, Karger H, Isacson R, Catane R, Glaser B. Recurrence-associated mortality in patients with differentiated thyroid carcinoma. J Surg Oncol 1993;52:164-8.
16. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992;112: 1139-47.
17. DeGroot LJ, Kaplan EL, Mccormick M, Straus FH. Nature, history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-24.
18. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985;55:805-28.
19. Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
20. Schindler AM, van Melle G, Evequoz B, Scazzifa B. Prognostic factors in papillary carcinoma of the thyroid. Cancer 1991;68: 324-30.
21. Ashcraft MW, Van Herle AJ. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer. Am J Med 1981;71:806-14.
22. Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994;79:98-105.
23. Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T. Thyroid carcinoma in Graves' disease. World J Surg 1990;14:437-44.
24. Hales IB, Mcelduff A, Crummer P, et al. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab 1992;75:886-9.